论文部分内容阅读
本文旨在探讨黄芪注射液在慢性活动性肝炎(CAH)中的临床疗效及应用价值。121例CAH住院患者随机分为治疗组和对照组,治疗组用黄芪注射液肌注,每日2次;对照组用垂盆草冲剂,每日3次。两组均以2个月为一疗程。结果显示:两组临床症状、体征的改善无差异(P>0.05),而治疗组的临床总有效率明显高于对照组(P<0.05),HDeAg转阴率明显高于对照组(P<0.01);治疗组IgG和补体C_3明显下降。提示黄芪注射液在促进肝细胞功能恢复的同时,调整和改善了机体的细胞免疫、体液免疫水平。
This article aims to investigate the clinical efficacy and application value of astragalus injection in chronic active hepatitis (CAH). 121 cases of CAH hospitalized patients were randomly divided into treatment group and control group, the treatment group with Astragalus injection intramuscular injection of 2 times a day; Both groups took 2 months as a course of treatment. The results showed that there was no difference in clinical symptoms and signs between the two groups (P> 0.05), but the total effective rate in the treatment group was significantly higher than that in the control group (P <0.05), and the HDeAg negative rate was significantly higher than that in the control group (P < 0.01). The IgG and complement C_3 in treatment group decreased significantly. Prompted Astragalus injection in promoting liver cell function recovery, while adjusting and improving the body’s cellular immunity, humoral immunity.